306 related articles for article (PubMed ID: 9543748)
1. [Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
Liem GS; Cornelissen JJ; Oudshoorn M; Sintnicolaas K; Löwenberg B; Hagenbeek A
Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1553-6. PubMed ID: 9543748
[TBL] [Abstract][Full Text] [Related]
2. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow transplantation in chronic myeloid leukemia].
Hansz J
Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB).
Akatsuka Y; Kodera Y; Yamamoto K; Minami S; Miyamura K; Morishita Y; Morishima Y; Saitoh H; Horibe K; Yamauchi T
Int J Hematol; 1992 Jun; 55(3):249-53. PubMed ID: 1498315
[TBL] [Abstract][Full Text] [Related]
5. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
[TBL] [Abstract][Full Text] [Related]
6. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia.
Drobyski WR; Pelz C; Kabler-Babbitt C; Hessner M; Baxter-Lowe LA; Keever-Taylor CA
Biol Blood Marrow Transplant; 1998; 4(1):3-12. PubMed ID: 9701386
[TBL] [Abstract][Full Text] [Related]
7. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
Chim CS; Lie AK; Liang R; Au WY; Kwong YL
Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
[TBL] [Abstract][Full Text] [Related]
9. Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors.
van Rhee F; Savage D; Blackwell J; Orchard K; Dazzi F; Lin F; Chase A; Bungey J; Cross NC; Apperley J; Szydlo R; Goldman JM
Bone Marrow Transplant; 1998 May; 21(10):1055-61. PubMed ID: 9632281
[TBL] [Abstract][Full Text] [Related]
10. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow transplantation from an unrelated donor in patient with congenital heart diseases].
Kumazaki H; Hanada R; Kikuchi A; Ichikawa M; Yamamoto K; Aoyagi H
Rinsho Ketsueki; 1996 Aug; 37(8):731-3. PubMed ID: 8827886
[TBL] [Abstract][Full Text] [Related]
12. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
Koldehoff M; Beelen DW; Trenschel R; Steckel NK; Peceny R; Ditschkowski M; Ottinger H; Elmaagacli AH
Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
[TBL] [Abstract][Full Text] [Related]
13. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results.
Gaziev D; Galimberti M; Polchi P; Angelucci E; Giardini C; Baronciani D; Andreani M; Persini B; Erer B; Sodani P; Manna M; Nicolini G; Visani G; Lucarelli G;
Bone Marrow Transplant; 2002 Jan; 29(1):1-8. PubMed ID: 11840137
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia.
Chiang KY; Van Rhee F; Godder K; Bridges K; Adams S; Mehta J; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Mar; 27(5):507-10. PubMed ID: 11313684
[TBL] [Abstract][Full Text] [Related]
16. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
[TBL] [Abstract][Full Text] [Related]
17. [Successful second transplant from one-locus HLA-mismatched unrelated donor for graft rejection following initial transplant from another unrelated donor in a patient with chronic myelogenous leukemia].
Tanaka M; Kanamori H; Kuwabara H; Yamaji S; Kamijo A; Taguchi J; Fujita H; Fujisawa S; Matsuzaki M; Mohri H; Ishigatsubo Y
Rinsho Ketsueki; 2001 Aug; 42(8):656-8. PubMed ID: 11579507
[TBL] [Abstract][Full Text] [Related]
18. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
